Publisher
Springer International Publishing
Reference16 articles.
1. Bahadar H, Maqbool F, Niaz K, Abdollahi M. Toxicity of nanoparticles and an overview of current experimental models. Iran Biomed J. 2016;20(1):1–11. https://doi.org/10.7508/ibj.2016.01.001. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689276/
2. Buchman JT, Hudson-Smith NV, Landy KM, Haynes CL. Understanding nanoparticle toxicity mechanisms to inform redesign strategies to reduce environmental impact. Acc Chem Res. 2019;52:1632–42. https://doi.org/10.1021/acs.accounts.9b00053.
3. Damasco JA, Ravi S, Perez JD, Hagaman DE, Melancon MP. Understanding nanoparticle toxicity to direct a safe-by-design approach in cancer nanomedicine – review. Nanomaterials. 2020; 10:2186, pp. 1–41. https://doi.org/10.3390/nano10112186.
4. European Parliament and Council. Regulation (EC). 2006. European Parliament and of the Council of 18 December 2006. No 1907/2006, concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation
5. (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. OJ EU 2006; L396:1.